Senior Doctors Call for Crackdown on Home Genetic Testing Kits
By Hannah Devlin,
The Guardian
| 07. 21. 2019
False results have told women they have mutations linked to breast and ovarian cancer.
Senior doctors have called for a crackdown on consumer genetic tests, following an influx of patients who have been wrongly told they are carrying dangerous mutations linked to cancer or other devastating conditions.
Women have been incorrectly informed by companies that they have faulty BRCA genes, which convey a high risk of breast and ovarian cancers. One patient was scheduled for preventive breast-removal surgery after a consumer genetic test suggested she had a BRCA mutation. The surgery was called off at the last moment when an NHS laboratory revealed the result to be a false positive.
Doctors warn that the issue is placing an increasing burden on GP surgeries and NHS genetics clinics, which are left to deal with the fallout when people receive alarming or confusing results.
“The NHS is incredibly irritated by these results because [in the case of BRCA] they’re more often wrong than right,” said Prof Anneke Lucassen, a clinical geneticist at Southampton University and chair of the British Society for Genetic Medicine. Lucassen said it was “terrifying” that one of her patients – and possibly...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...